Get started
Author

Yanping Liu

Observed name: Weidong Li
Observed institutions: Nanfang Hospital, Henan Cancer Hospital, Karamay Central Hospital, Guangzhou Medical University Cancer Hospital, CSPC Pharmaceutical Group, Southern Medical University, University of South China
ORCID: 0000-0002-8338-5991
Observed ORCID: 0000-0002-8338-5991
OpenAlex ID: A5087227832
Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study
2023 · Yangda Song, Guangyao Zhou, et al. · Hepatology International · 40
Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T‐cell and natural killer‐cell neoplasms: A phase 2, multicenter, open‐label, single‐arm trial
2025 · Yan Gao, Yunhong Huang, et al. · Cancer · 17
PDF
Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study
2025 · Ying Fan, Qingyuan Zhang, et al. · Nature Communications · 11
PDF
Mitoxantrone hydrochloride liposome injection for the treatment of Recurrent/Metastatic head and neck squamous cell Carcinoma: A Multicenter, Open-label, Single-arm, phase 1b study
2025 · Hang Yang, Peng Sun, et al. · Oral Oncology · 5
Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma
2022 · Shufang Yan, Qinyu Shang, et al. · Journal of Immunology Research · 4
PDF
Noni ( Morinda citrifolia L.) Fermented Juice Inhibits Tumor Progression of Breast Cancer Angiogenesis Through Suppressing NF‐κB Signaling
2026 · Baijian Wu, Xiaoyu Xu, et al. · Food Frontiers · 1
NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial
2026 · Chuntao Gao, Yanqiao Zhang, et al. · Nature Communications · 1
PDF
A phase 1 study of liposomal irinotecan in patients with advanced breast cancer.
2024 · Ying Fan, Qingyuan Zhang, et al. · Journal of Clinical Oncology
A phase II study of liposomal irinotecan-based chemotherapy with or without PD-1 inhibitor in patients with unresectable locally advanced or metastatic biliary tract cancer.
2024 · Jieer Ying, Xiangdong Cheng, et al. · Journal of Clinical Oncology
PDF
Works count: 10
Citation count: 84
H-index: 5
I10-index: 3
Year
Topic
Type